Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes Read more about Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy Read more about RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm Read more about Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II) Read more about Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease Read more about A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice Read more about A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas Read more about Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma Read more about A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
CatchU: A Quantitative Multisensory Falls-Assessment Study Read more about CatchU: A Quantitative Multisensory Falls-Assessment Study